{"id": "chatcmpl-8JZmmdgLx9kivEhyu3vhOywTMdlAm", "object": "chat.completion", "created": 1699676484, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. All groups showed significant antihypertensive effects at Week 4.\n2. CKD-828 combinations exhibited superior BP-lowering effects than S-amlodipine 2.5 mg at Week 4.\n3. The two CKD-828 combinations tested were CKD-828 2.5/40 mg and CKD-828 2.5/80 mg.\n4. The BP-lowering effect of CKD-828 2.5/40 mg was significantly superior to S-amlodipine 2.5 mg (sitDBP/SBP: P=0.0028/P=0.0001).\n5. The BP-lowering effect of CKD-828 2.5/80 mg was significantly superior to S-amlodipine 2.5 mg (P<0.0001/P=0.0012)."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 184, "total_tokens": 314}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: At Week 4, all groups showed significant antihypertensive effects but both CKD-828 combinations (CKD-828 2.5/40 mg and CKD-828 2.5/80 mg) exhibited superior BP-lowering effects to that of S-amlodipine 2.5 mg (sitDBP/SBP: P=0.0028/P=0.0001 and P<0.0001/P=0.0012, respectively).\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}